ARCHIVES

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

HHS Approves Six State Plans To Insure Women With Cancer

June 8, 2001

Oncology Practice Group Leaves Allegheny For Former Rival UPCI; Will NSABP Follow?

June 30, 2000

In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List

May 23, 1980

Wisconsin Group Takes Lead In Challenging Pain Control Perception

April 21, 1989

Clearinghouse Finds Seven Compounds Are Carcinogenic, Human Threat

September 1, 1978

House Expected To Eliminate Earmarks, give NCI $2 Billion For FY94, A $40 Million Increase

June 18, 1993